New Formulation Of Lotrel(R), 10/20 mg, Now Available

Market Wire, 20050229

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE: NVS), a world leader in healthcare with core businesses in pharmaceuticals, consumer health, generics, eye-care, and animal health. In 2001, the Group's businesses achieved sales of CHF 32.0 billion (USD 19.1 billion) and a net income of CHF 7.0 billion (USD 4.2 billion). The Group invested approximately CHF 4.2 billion (USD 2.5 billion) in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 72,600 people and operate in over 140 countries around the world. For further information please consult www.novartis.com.

Norvasc(R) is a registered trademark of Pfizer, Inc. The amlodipine active ingredient found in Lotrel is supplied to Novartis Pharmaceuticals Corporation by Pfizer, Inc.

For full prescribing information contact Christine Landy at (973) 781-8026 or consult www.pharma.us.novartis.com/product/pi/pdf/lotrel.pdf.